Michael Senken

SEC Charges Former MiMedx Execs With Fraud
Risk & Compliance

SEC Charges Former MiMedx Execs With Fraud

The C-suite executives allegedly improperly recognized revenue from distributors with which MiMedx had secret side arrangements.
By Matthew Heller | November 27, 2019
Read More
MiMedx Announces Restatement, Replaces CFO
People

MiMedx Announces Restatement, Replaces CFO

The biotech firm's stock falls 23% but its CEO says, "It is important that investors understand that our business performance remains strong."
By Matthew Heller | June 7, 2018
Read More